CN1056982C - "Xuebaodan"-medicine for nourishing blood and production technology thereof - Google Patents
"Xuebaodan"-medicine for nourishing blood and production technology thereof Download PDFInfo
- Publication number
- CN1056982C CN1056982C CN94113998A CN94113998A CN1056982C CN 1056982 C CN1056982 C CN 1056982C CN 94113998 A CN94113998 A CN 94113998A CN 94113998 A CN94113998 A CN 94113998A CN 1056982 C CN1056982 C CN 1056982C
- Authority
- CN
- China
- Prior art keywords
- medicine
- production technology
- blood irradiation
- xuebaodan
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention discloses a medicine named as Xuebaodan and the production technology thereof, and the medicine is prepared from the ingredients of excrementum bombycis, chuanxiong rhizome and peach seed. The medicine has obvious effect on enhancing blood radiation.
Description
The present invention relates to a kind of medicine and production method thereof.
Ultraviolet blood irradiation has become one of main means of treatment cardiovascular and cerebrovascular disease and tumor, but how to improve the curative effect of ultraviolet blood irradiation and reduce its side effect, and the someone inquires into as yet.
The object of the present invention is to provide a kind of adjuvant and production technology thereof that has efficient photosensitization, raising ultraviolet blood irradiation curative effect and reduce the ultraviolet blood irradiation therapy of its side effect
Technical solution of the present invention is:
A kind of adjuvant of ultraviolet blood irradiation therapy, the difference of itself and prior art is: the composition of raw material and consumption are:
Silkworm excrement 10~40% Rhizoma Chuanxiongs 20~60%
Semen Persicae 20~50%.
A kind of production technology of adjuvant of ultraviolet blood irradiation therapy is mixed general ball by the composition by weight of following traditional Chinese medicine raw, makes pill:
Silkworm excrement 10~40% Rhizoma Chuanxiongs 20~60%
Semen Persicae 20~50%.
Product of the present invention has obvious curative effects when being used for the ultraviolet blood irradiation treatment.This product has efficient photosensitization, the side effect that the minimizing ultraviolet blood irradiation may occur etc.
The invention will be further described below in conjunction with embodiment:
Embodiment; Get silkworm excrement, Rhizoma Chuanxiong, Semen Persicae composition and press column weight amount component and mix general ball, make pill;
Silkworm excrement 30% Rhizoma Chuanxiong 40%
Semen Persicae 30%.
During concrete the making, with above-mentioned in each medicinal direct comminuting method, ethanol extraction method, decocting extracting juice method make medicated powder, two kinds of forms of medicinal liquid.Molding then, promptly get a certain amount of medicated powder earlier, add a certain amount of medicine juice and stir, make soft material (with hands rub agglomerating, by be the degree that promptly looses) granulation of 18 orders, the 20-22 mesh sieve removes thick piece, put in the coating pan, add medicine juice dosing powder and make a certain size female ball, 40 mesh sieves remove fine powder, and 30 mesh sieves remove thick piece, promptly get the ball mould, at below 70 ℃ dry 3 hours.Carry out molding then, the female ball that is about to a certain size is put in the coating pan, the spray medicine juice, with the powder degree of being of 40-45Kg/100Kg, adding medicated powder dosing juice needs uniform distribution, and consumption is moderate, and constantly with hand rubbing flour piece, folded ball, and turn from inside to outside, pill is evenly increased, because the rotation of machine makes big grain concentrate on the pot mouth, granule concentrates on the bottom of a pan, so when adding powder, should be added near the bottom of a pan, make piller adhere to medicated powder, it is poor to dwindle pill.Be accelerated into ball speed during molding, strict control rolling time adds a back rolling 3-4 minute and is advisable, and will suitably increase the powder amount of using at every turn, not produce too much piller degree of being, constantly add medicine juice and add powder, general repeatedly system is sieved in accordance with regulations and is graded step by step, during nearly finished product, with the medicated powder capping of certain fineness, more than 20 orders, till 18 orders are following.
Also carry out drying, glazing, sterilization treatment after becoming ball, detailed process is: (1) drying: about 80 ℃ on the wet ball of general system is dry, regularly stir, and evenly dry; (2) glazing: dried pill is crossed 20 orders, 18 orders, get about the pill 20Kg on following 20 orders of 18 orders and put in the polishing pot, add 0.1-0.2% rice heart wax rolling pill surface-brightening and get final product.(3) sterilization: pressure sterilizing (about 120 ℃, 15-20 minute) sterilization is rearmounted cold, goes into oven drying 1-2 hour.Use ethylene oxide sterilizing after also can be packagedly finishing in addition.Pack then.
This product is an oral formulations, takes in 1-2 hour before carrying out ultraviolet blood irradiation, each 2.5 grams.
Embodiment 2:
When general ball was made pill, each Chinese medicine ingredients proportioning was:
Silkworm excrement 20% Rhizoma Chuanxiong 35%
Semen Persicae 45%
All the other are all with embodiment 1.
Embodiment 3:
When general ball was made pill, each Chinese medicine ingredients proportioning was:
Silkworm excrement 30% Rhizoma Chuanxiong 50%
Semen Persicae 20%
All the other are all with embodiment 1.
Case: the week * * male 53 years old
Because of the ischemic cerebral thrombosis, the left limb hemiplegia is at the local hospital low right side of warp, Radix Salviae Miltiorrhizae, ultraviolet blood irradiation treatment etc., left limb functional rehabilitation poor (V level → IV level).This center treatment is changeed in the back, gives this Chinese medicine, ultraviolet blood irradiation treatment, the obvious IV level of left limb functional rehabilitation → II level).The state of an illness is clearly better.Obey the curative effect of this Chinese medicine front and back treatment cardio-cerebral diseases 264 examples during the ultraviolet blood irradiation treatment:
Microcirculation function changes before and after obeying this Chinese medicine
Normally | Unusually | |
Heavy in light | ||
Treat preceding 0 | 0 78 186 | |
After the treatment | Do not obey this Chinese medicine 4 | 37 133 69 |
Obey this Chinese medicine 26 | 148 67 23 |
Ultraviolet blood irradiation treatment side reaction changes before and after obeying this Chinese medicine
The giddy of heating erythra
Do not obey this Chinese medicine 19 25 31
Obey this Chinese medicine 38 12
Can obviously increase therapeutic effect after taking this Chinese medicine during the ultraviolet blood irradiation treatment, alleviate its side effect.
Claims (2)
1, a kind of adjuvant of ultraviolet blood irradiation therapy is characterized in that: the composition of raw material and consumption are:
Silkworm excrement 10~40% Rhizoma Chuanxiongs 20~60%
Semen Persicae 20~50% is made through general ball.
2, a kind of production technology of adjuvant of ultraviolet blood irradiation therapy is characterized in that: the composition by weight by following traditional Chinese medicine raw mixes general ball, makes pill:
Silkworm excrement 10~40% Rhizoma Chuanxiongs 20~60%
Semen Persicae 20~50%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN94113998A CN1056982C (en) | 1994-11-21 | 1994-11-21 | "Xuebaodan"-medicine for nourishing blood and production technology thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN94113998A CN1056982C (en) | 1994-11-21 | 1994-11-21 | "Xuebaodan"-medicine for nourishing blood and production technology thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1123155A CN1123155A (en) | 1996-05-29 |
CN1056982C true CN1056982C (en) | 2000-10-04 |
Family
ID=5036954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN94113998A Expired - Fee Related CN1056982C (en) | 1994-11-21 | 1994-11-21 | "Xuebaodan"-medicine for nourishing blood and production technology thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1056982C (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1083707A (en) * | 1992-09-05 | 1994-03-16 | 沈阳康达制药厂 | A kind of production technology of NAOXUESHUAN PIAN |
-
1994
- 1994-11-21 CN CN94113998A patent/CN1056982C/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1083707A (en) * | 1992-09-05 | 1994-03-16 | 沈阳康达制药厂 | A kind of production technology of NAOXUESHUAN PIAN |
Non-Patent Citations (1)
Title |
---|
浙江中医学院学报1989年13卷2期 1989.1.1 俞丽霞等,中医光敏剂对动物慢性毒理实验的研究 * |
Also Published As
Publication number | Publication date |
---|---|
CN1123155A (en) | 1996-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101181559B (en) | Preparation method of Chinese medicine preparation for curing fungi dermatosis | |
CN101019975A (en) | Fracture treating Chinese medicine composition and its prepn | |
CN1029081C (en) | Productive method for Chinese Cpd. medicine "Sang-ji-Dan" | |
CN1056982C (en) | "Xuebaodan"-medicine for nourishing blood and production technology thereof | |
CN1067254C (en) | Traditional Chinese medicine pill "Guan-mai-dan" for curing coronary heart disease and the like | |
CN1067273C (en) | Pearl oropharyngeal powder | |
CN1105557A (en) | Method for preparation of weight-loosing medicine and its products | |
CN1060054C (en) | "Funaowan"-medicinal pill for recovering brains and production technology thereof | |
CN1225259C (en) | A Chinese patent medicines fomula for curing cerebral arteriosclersis and the preparation process thereof | |
CN102166329B (en) | Medicine for treating leukopenia caused by chronic hepatitis B or interferon and preparation method thereof | |
CN100358552C (en) | Medicine for treating amblyopia and its preparing method | |
CN1070379C (en) | Medicine for adjusting human body functions and process for producing the same | |
CN1056983C (en) | "Xianludan"-medicine and production technology thereof | |
CN1073409C (en) | Method for preparing medicinal mask composition, and products thereby | |
CN1062453C (en) | Rehabilitation pill for brains and its production technology | |
CN1061868C (en) | Chinese patent medicine for treating impotence and prospermia | |
CN1072014C (en) | Fat reducing pill and producing technology | |
CN1059582C (en) | Traditional Chinese medicine of set prescription with function of promoting intelligence and prolonging life-span | |
CN1056981C (en) | "Tongmailing" -medicine for promoting blood-circulation and production technology thereof | |
CN1056984C (en) | "Zuliudan"-medicine for resisting tumor and production technology thereof | |
CN1165334C (en) | Shalian regulating stomach-energy capsule (contg. Fructus and Fructus Forsythiae) | |
CN1084198C (en) | Psoriasis treating Chinese medicine bolus | |
CN115919988A (en) | Preparation method of thrombus-eliminating and collateral-dredging tablet | |
CN115211559A (en) | Pill for protecting kidney, strengthening waist and nourishing liver and preparation method thereof | |
CN1228987A (en) | Medicine for treating heart disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |